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Abstract. The CHA2DS2-VASC score has been reported recently to predict adverse clinical 
outcomes so is CIN in patients with AMI regardless of having AF. We investigated 
relationship between CHA2DS2-VASC score with CIN in patients who underwent PCI 
strategies. This is a study of 40 patients with and underwent PCI. The CHA2DS2-VASC 
score was calculated for each patient. From this study 16 cases(18.82%) of CIN were 
diagnosed. CIN was defined as rise in serum creatinine>0,5mg/dL or>25% increase in 
baseline within 24h after PCI. In the ROC curve analysis,the cut-off value of CHA2DS2-
VASC score in the prediction of CIN 
was>4(sensitivity:56.25%,Specificity:87.5%)(AUC0.698,95%:CI1.460-6.163,p=0.003) and 
has a significant association with CIN(R20.485). We also identified Hb level<12mg/dL as 
an independent predictor of CIN with (RR3.44,95%:CI1.816-6.532,p<0.001). The 
CHA2DS2-VASC score was positively associated with CIN. Therefore,it can be used as a 
simple and reliable tools to predict CIN in AMI patients who underwent PCI. 
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1 Introduction 
Cardiovascular disease (CVD) is a leading cause of death worldwide (WHO, 2014).Renal injury 
as one of its adverse outcome is increasingly being seen in patients with acute myocardial 
infarction (AMI). As well as  renal impairment can also be found due to the use of contrast agent 
in the setting of AMI patients who underwent percutaneous coronary intervention (PCI) known 
as Contrast Induced Nephropathy (CIN) (Gleeson, 2004). 
Some study recently described the components of CHA2DS2-VASC score such as older age, 
hypertension, diabetes mellitus, heart failure, and female as a novel predictor of severity and also 
adverse outcomes in cardiovascular disease including CIN, despite of having atrial fibrillation 
(Kurtul, 2017; Marenzi, 2004). Thus, we aimed to investigate thepredictive value of CHA2DS2-
VASC score as a simple toolfor CIN in patients with ACS who underwent PCI. 
2. Methodology 
This was a single center study in which a total of 40 consecutive acute coronary syndrome (ACS) 
patients from total 84 patients ACS who underwent PCI at our hospital. The exclusion criteria 
was patients with hypotension state during PCI or using any inotropic for stabilizing 
haemodynamic, shock cardiogenic, atrial fibrillation,  and patients with post cardiac resuscitation. 
Clinical and demographic characteristicswere obtained bymedical history, physical examination, 
electrocardiographicfindings, echocardiographic examination, and laboratory data. The 
CHA2DS2-VASC score was calculated foreach patientwith the lowest score was 1 and the highest 
score was 9, because all of the patients consider have vascular disease due to AMI.The study was 
approved bythe local ethics committee, and all patients provided theirwritten informed consent 
(Kurtul, 2017). 
Baseline serum creatinine was determined atadmission, and serum creatinine measurement was 
repeated 24 after PCI. The eGFR was calculatedusing the Cockroft-Gault formulaand using the 
serum creatinine measured at admission.Routine hemogram parameters, fasting lipid profiles, 
fasting glucose, 2 hours post prandial glucose, HbA1C, and serum electrolytes were 
alsomeasured. CIN was defined as the elevation of serumcreatinine 0.5 mg/dl or 25% in baseline 
serum creatininewithin 24 hours after PCI (McCullough, 2008). 
All statistical analyses were performed using statistical software, and a p value<0.05 was 
considered significant. Receiver operatingcharacteristic curve analysis was used to determine the 
optimumcut-off valuesof CHA2DS2-VASC score to predictthe development of CIN. Data were 
comparedwith the use of Student t or ManneWhitney U test forcontinuous variables (expressed 
as meanstandarddeviation for parametric variables and median and interquartileranges [25 to 75 
percentile levels] for nonparametricvariables) and the chi-square or Fisher’s exact test for 
categoricalvariables (expressed as counts and percentages). Continuous variables were analyzed 
for normal distributionusing the KolmogorovSmirnov test. To address concernsover confounding 
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variables affecting CIN development, wealso performed a multivariate logistic regression 
analysis.Variables significantly associated with CIN, but notincluded in the calculation of the 
CHA2DS2-VASC score,were entered into the multivariate model. 
3. Results 
From total of 85 ACS patients who were admited to our cardiac care unit, 40 patient were enrolled 
to our study, and 16 patients were diagnosed with CIN (18.82%). The mean age of our study 
population was 54.28 + 8.121 years, and the mean CHA2DS2-VASC score was 1.82 + 1.152.  
On bivariate analysis, CHA2DS2-VASC score >4 (relative risk [RR] 3, 95%CI 1.460-6.163; 
p=0.003), Hb level < 12mg/dL (relative risk [RR] 3.44, 95%CI 1.816-6.532; p<0.001), eritrosit 
level (relative risk [RR] 2.778, 95%CI 1.268-6.084; p=0.008), hematokrit level (relative risk [RR] 
4.09, 95%CI 1.582-10.412; p<0.001), HDL level (relative risk [RR] 1.8, 95%CI 0.766-4.229; 
p=0.154), and Mehran score (relative risk [RR] 0.491, 95%CI 0.221-1.090; p=0.069) (Table 2) 
From multivariate analysis CHA2DS2-VASC score >4 and Hb level < 12 mg/dL 
wereindependent predictors for CIN after urgent PCI in patientswith ACS (R2 0.485) (Table 4). 
 
4.  Discussion 
The present study demonstrated that the CHA2DS2-VASC score >4 was independently 
associated with CINdevelopment in patients with ACS who were treated byurgent 
PCI.CIN, an important complication after PCI, especially inthe setting of ACS, is 
associated with extended length ofhospital stays, increased costs, and increasedshort- 
andlong-term morbidity and mortality.Althoughpathophysiological mechanisms of CIN 
is not fullyunderstood, researchers concluded that CIN is caused byrenal vasoconstriction, 
endothelial dysfunction, endotheliumcell damage, followed by renal tubular injury and 
medullaryhypoxia (Mehran, 2006). From previous study advanced age, female gender, 
diabetes mellitus,CHF, and renal dysfunctionare already wellknownrisk factors for 
CIN.The components of the CHA2DS2-VASC score include similar risk factors for CIN 
so there are opinion arise that CHA2DS2-VASC score can also predict the CIN event. 
From multivariate analysis in this study we conclude that CHA2DS2-VASC score was 
an independent risk factor for CIN regardless having AF. 
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Figure 1. ROC Curve Analysis for The Presenceand Number of CHA2DS2-VASC 
Scores for Predicting Contrast-Inducednephropathy. 
 
 
Table 1. Significancy Value of CHA2DS2-VASC Score 
 
 
Positive if Greater 
Than or Equal To 
Sensitivity 1-Specificity 
.00 1.000 1.000 
1.50 .938 .833 
2.50 .688 .500 
3.50 .562 .083 
4.50 .125 .042 
6.00 .000 .000 
 
 
Table 2. Bivariate Analysis of Independent Predictors Of CIN 
 
Variable 95% CI RR 
CIN 
p-value 
Yes  No 
HR      < 74 
      ≥ 74 
1.13-17.07 2.42 11 
5 
8 
16 
0.051 
Hb      < 12 
      ≥ 12 
1.816-6.532 3.44 8 
 8 
1 
23 
<0.001 
Erit.     <4.5                          
     ≥ 4.5 
1.268-6.084 2.778 10 
6 
5 
19 
0.008 
Ht       < 39 
     ≥ 39 
1.582-10.412 4.09 12 
4 
5 
19 
0.001 
Mehran < 9 
        ≥ 9 
0.221-1.090 0.491 6 
16 
10 
8 
0.069 
 
CHA2DS2-VASc             
             < 4 
       ≥ 4 
 
1.460-6.163 
 
3 
 
9 
7 
 
3 
21 
 
0.003 
HDL   > 40 
      < 40 
0.766-4.229 1.80 5 
11 
13 
11 
0.154 
      
Area P value 
0.698 0.036 
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Recently,Kurtul et alhave concluded a CHA2DS2-VASC score of > 4is an independent 
predictor for incidence. There is no difference of cut off point despite small sample size 
in our study and differences of patients characteristic in our study.Also, we compare the 
association in predicting CIN with Mehran score. In bivariate and multivariate analysis, 
the CHA2DS2-VASC score has more association in predicting CIN than Mehran score, 
but this finding must be tested in larger sample. 
 
Tabel 3. Multivariate Model Analysis of Independent Factors of CIN 
Step -2 Log 
likelihood 
Cox & Snell 
R Square 
Nagelkerke 
R Square 
1 30.592a .441 .596 
2 32.898b .408 .551 
3 34.104b .389 .527 
4 36.086b .358 .485 
          
From this study we found that dyslipidemia, smoker, and family history as risk factor of 
CAD has significant value in CIN (+) group. The combined oxidative stress, 
inflammation and dyslipidemiacan accelerate atherosclerosis, the basic pathophysiology 
of all kinds of vascular disease (Park, 2016). 
The present study had some limitations. First, the presentstudy was a single-center study 
and has small  sample.  Second, we don’t fully assessed the kind of contrast media as 
confounders of CIN. Finally, we also don’t predict others adverse outcome such MACE 
in our study. 
5.  Conclusion 
From this study we can conclude CHA2DS2-VASC score can be used as a simple, more 
reliable tool topredict CIN in patients who underwent PCI. 
 
Characteristic 
CIN Event  
P value CIN (+) 
(n=16) 
CIN (-) 
(n=24) 
Age (years) 53.12 ± 9.062 55.04 ± 7.532 0.472 
Sex Category (n,%) 
     Male 
     Female 
 
12 (30%) 
4 (10%) 
 
19 (47.5%) 
5 (12.5%) 
 
0.757 
Diabetes Mellitus (n,%)  8 (20%)  8 (20%) 0.292 
Hipertension (n,%) 11 (27.5%) 14 (35%) 0.505 
Dislipidemia (n,%) 12 (30%) 8 (20%) 0.010 
Smoker(n,%) 11 (27.5%)  8 (20%) 0.028 
Family History (n,%) 12 (30%) 6 (15%) 0.002 
CHF (n,%) 10 (25%) 8 (20%) 0.069 
Stroke (n,%) 1 (2.5%) 0 (0%) 0.215 
Vascular Disease (n,%) 1 (2.5%) 0 (0%) 0.215 
Laboratorium 
    Hb 
    Hematokrit 
    Ureum pre PCI 
    Creatinin pre PCI 
    CrCl 
 
12.1562 ± 1.95345 
35.75 ± 5.615 
46.38 ± 49.679 
1.3706 ± 1.16101 
84.0000 ± 44.88058 
 
14.3500 ± 1.29581 
43.29 ± 4.486 
35.29 ± 17.652 
.9958 ± .38528 
88.1667 ± 30.02414 
 
<0.001 
<0.001 
0.320 
0.149 
0.726 
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    Ureum post PCI 
    Creatinin post PCI 
    HDL 
64.50 ± 51.024 
2.8131 ± 3.67862 
33.00 ± 10.614 
35.21 ± 16.59 
.9287 ± .24503 
41.54 ± 11.595 
0.012 
0.016 
0.024 
 
     Table 3. Baseline Characteristic 
REFERENCES 
[1] Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol.   
 2004;183:1673– 89. 
[2] Kurtul A, Yarlioglues M, Duran M. Predictive value of CHA2DS2-VASC score for contrast 
 induced nephropathy after percutaneus coronary intervention for acute coronary syndrome.
 Am J Cardiol. 2017;119:819-825. 
[3] Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing 
 primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780-5. 
[4] McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-
 1428. 
[5] Mehran R, Nikolsky E. Contrast-induced nephropathy: Definition, epidemiology, and 
 patients at risk. Kidney Int Suppl. 2006;100:11-15. 
[6] Park HS, Kim CS, Hwang BH, Kim TH, Koh YS, Park HJ, et al. HDL Cholesterol Level Is 
 Associatedwith Contrast Induced Acute KidneyInjury in Chronic Kidney DiseasePatients 
 Undergoing PCI. Scientific Reports. 2016.6:35774. 
[7] World Health Organization. Global Health Estimates: Deaths by cause, age, sex, and country, 
 2000-2012. Geneva: WHO. 2014. 
